Week Ending October 17, 2022

Barriers Remain for Better Hepatitis C Virus Care
“Treatment initiation was lower among Medicaid and private health insurance recipients aged 18-29 years, compared with patients aged 50-59 years.”

Global Rates of Liver Cancer Could Rise by More Than 50 Percent by 2040
“Primary liver cancer was among the top three causes of cancer death in 46 countries in 2020, and the number of people diagnosed with or dying from primary liver cancer per year could rise by more than 55 percent by 2040, according to a new global analysis. To avoid this increase, countries need to lower the annual rate of liver cancer incidence and death by at least 3 percent, according to the findings, published on October 5 in the Journal of Hepatology.”

Seroprevalence of Hepatitis B Virus, Hepatitis C Virus, Syphilis and Associated Factors Among Female Sex Workers in Gondar Town, Northwest Ethiopia
“Sexually transmitted infections (STIs) are a public health problem worldwide. Hepatitis B virus infection (HBV), hepatitis C virus infection (HCV), and syphilis are among the STIs. Female sex workers (FSWs) continue to be a high-risk group for STIs due to a variety of factors, including exposure to unsafe sexual practices. Therefore, this study determines the seroprevalence of HBV, HCV, Treponema palladium, and associated factors among FSWs in Gondar town, Northwest Ethiopia.”

Hepatitis A Vaccination Efforts Can Reduce Spread
“Vaccination efforts have lead to a reduction in hepatitis A outbreak-affected states, and this progress should be encouraged to continue, according to the US Centers for Disease Control and Prevention’s Morbidity and Mortality Weekly Report.”

Economic Impact of Universal Hepatitis C Virus Testing for Middle-Aged Adults Who Inject Drugs
“The objective of this study was to estimate the economic impact of providing universal hepatitis C virus testing in commercially insured middle-aged persons who inject drugs in the U.S.”